Zacks Research Has Pessimistic Outlook of Amdocs Q4 Earnings

Amdocs Limited (NASDAQ:DOX) – Analysts at Zacks Research cut their Q4 2027 earnings estimates for Amdocs in a note issued to investors on Wednesday, August 26th. Zacks Research analyst Team now expects that the technology company will post earnings of $1.83 per share for the quarter, down from their previous forecast of $1.87. The consensus estimate for Amdocs’ current full-year earnings is $6.57 per share. Zacks Research also issued estimates for Amdocs’ Q1 2028 earnings at $1.88 EPS.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Thursday, August 6th. The technology company reported $1.84 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.84. The business had revenue of $1.17 billion for the quarter, compared to analysts’ expectations of $1.18 billion. Amdocs had a return on equity of 20.28% and a net margin of 9.75%.The company’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period last year, the firm earned $1.72 earnings per share.

DOX has been the topic of a number of other research reports. KeyCorp began coverage on Amdocs in a research report on Monday, June 29th. They issued a “sector weight” rating on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a research report on Wednesday, August 5th. Cfra lowered shares of Amdocs to a “sell” rating in a research note on Thursday, May 14th. Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a report on Sunday, July 5th. Finally, Stifel Nicolaus reduced their target price on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Three research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $86.67.

Amdocs Trading Up 0.7%

DOX opened at $62.70 on Friday. Amdocs has a 12 month low of $49.74 and a 12 month high of $87.10. The stock has a market capitalization of $6.77 billion, a price-to-earnings ratio of 14.93, a PEG ratio of 1.08 and a beta of 0.40. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.94 and a quick ratio of 0.94. The business has a fifty day moving average price of $54.87 and a 200 day moving average price of $61.20.

Amdocs Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.569 dividend. This represents a $2.28 annualized dividend and a yield of 3.6%. The ex-dividend date of this dividend is Wednesday, September 30th. Amdocs’s dividend payout ratio is 54.05%.

Institutional Trading of Amdocs

A number of institutional investors have recently bought and sold shares of the business. Pzena Investment Management LLC boosted its position in shares of Amdocs by 82.6% during the 4th quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock worth $969,100,000 after acquiring an additional 5,443,766 shares in the last quarter. Alyeska Investment Group L.P. increased its holdings in shares of Amdocs by 155.1% in the 4th quarter. Alyeska Investment Group L.P. now owns 2,110,393 shares of the technology company’s stock valued at $169,908,000 after acquiring an additional 1,283,231 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Amdocs by 19.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company’s stock worth $226,045,000 after acquiring an additional 571,036 shares in the last quarter. Squarepoint Ops LLC raised its position in shares of Amdocs by 469.4% during the 4th quarter. Squarepoint Ops LLC now owns 543,875 shares of the technology company’s stock worth $43,787,000 after acquiring an additional 448,358 shares in the last quarter. Finally, Voloridge Investment Management LLC lifted its stake in Amdocs by 501.1% during the fourth quarter. Voloridge Investment Management LLC now owns 520,494 shares of the technology company’s stock worth $41,905,000 after purchasing an additional 433,907 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.